Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-424-3 | CAS number: 95-49-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 18 February 1982 to 28 June 1982
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Colony sizing not reported
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 982
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
Test material
- Reference substance name:
- 2-chlorotoluene
- EC Number:
- 202-424-3
- EC Name:
- 2-chlorotoluene
- Cas Number:
- 95-49-8
- Molecular formula:
- C7H7Cl
- IUPAC Name:
- 1-chloro-2-methylbenzene
- Test material form:
- liquid
- Details on test material:
- purity not specified, or relating to pure substance in case of QSAR
Constituent 1
Method
- Target gene:
- TK locus
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9: adult, male Sprague Dawley ratsm, Aroclor 1254 induced
- method of preparation of S9 mix: prepared according to method of the laboratory
- concentration or volume of S9 mix and S9 in the final culture medium: 0.3 nl/10mL - Test concentrations with justification for top dose:
- without metabilit activation:
Experiment 1: 1.95, 3.91, 7.81, 15.6, 31.3 nl/ml
Experiment 2: 7.5, 10, 15, 20, 30, 40 nl/ml
with metabolic activation:
Experiment 1: 3.91, 7.81, 15.6, 31.3, 62.5 nl/ml
Experiment 2: 10, 15, 20, 30, 40, 60 nl/ml - Vehicle / solvent:
- DMSO
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: ethylmethane sulfonate; dimethylnitrosamine
- Remarks:
- ethylmethane sulfonate is used as positive control substance for assay without metabolic activation
dimethylnitrosamine is used as positive control substance for assay with metabolic activation
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of independent experiments: 4 (trial 3 was terminated due to contamination)
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding (if applicable):
- Test substance added in medium; in agar (plate incorporation); preincubation; in suspension; as impregnation on paper disk
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 4 h
FOR GENE MUTATION:
- Expression time (cells in growth medium between treatment and selection): 2 - 3 days
- Selection time: 3 x 10E 6 cells for each selected dose are seeded in soft agar plates with selection medium and resistant (mutant) colonies are counted after 10 days incubation.
- Method used: agar
- selective agent: -bromo-2' deoxyuridine (BrdU), selectin medium contains 100 µg/ml BrdU
METHODS FOR MEASUREMENT OF CYTOTOXICITY
Relative cytotoxicities is expressed as the reduction in growth compared to the growth of untreated cells. This is used to select seven to ten doses in the range of 0 to 50-90% reduction in the 24-hour growth.
METHODS FOR MEASUREMENTS OF GENOTOXICIY
To determine the actual number of cells capable of forming colonies, a portion of the cell suspension is also cloned in normal medium (nonselective). The ratio of resistant colonies to total viable cell number is the mutant frequency.
Results and discussion
Test results
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: without: 40 nl/ml; with: 60 nl/ml
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Without metabolic activation , the test material was cytotoxic at 62.5 nl/ml. Five treatments from 1.95 nl/ml to 31.3 nl/ml were therefore chosen for mutant analysis in an attempt to obtain a wide range of toxic action. None of the assayed treatments induced a mutant frequency that exceeded the minimum criterion of 31.7x10 E-6. However, only moderate toxicities were induced (percent relative growths, 62.1% to 39.9%). Since it is preferable to include in the evaluation results from treatments that induced high toxicities (percent relative growths, 10% to 15%), another assay was performed.
In the second experiment without metabolic activation, the test material was assayed from 7.5 nl/ml to 40 nl/ml with small increments between concentrations. The assayed treatments induced percent relative growths ranging from 58.3% to 19.3% which included moderate toxicites. A sharp toxicity curve prevented analysis of highly toxic treatments; the next highest concentration (60 nl/ml) was lethal. In order for a treatment to be considered mutagenic in this assay a mutant frequency exceeding 38.5x10 E-6 was required and the assayed treatments induced mutant frequencies ranging from 10.9x10E- 6 to 23.7x10E- 6 . Since no evidence for mutagenic activity activity was observed, the test material was considered nonmutagenic without activation at oncentrations that approached lethality.
In the presence of metabolic activation, the test material was assayed from 10 nl/ml to 60 nl/ml. The minimum criterion for mutagenicity in this assay was a mutant frequency exceeding 52.4x 10E-6 . None of the assayed treatments induced this level of mutant action. The observed toxicities ranged from nondetectable to moderate (percent relative growths, 127.1% to 23.8%). High toxicities could not be analyzed because of a sharp toxicity curve (80 nl/ml was excessively toxic).
The test material was therefore considered nonmutagenic with activation at treatments that approached excessive toxicity. In the assays used in this evaluation, the average cloning efficiencies for the solvent and untreated negative controls varied from 80.1% and 84.4% without activation to 76.8% with activation which demonstrated good cloning conditions for the assays. The negative control mutant frequencies were all in the normal range and the positive control compounds yielded normal mutant frequencies that were greatly in excess of
the background.
For details on results see illustration below.
Any other information on results incl. tables
Applicant's summary and conclusion
- Conclusions:
- In an mammalian cell gene mutation assay performed similar to OECD test guideline 476 with mouse lymphoma L5178Y cells under GLP conditions, the test substance was negative in two separate experiments with and without metabolic activation.
- Executive summary:
2-chlorotoluene was tested in the mouse lymphoma assay with and without metabolic activation (Aroclor-induced rat liver S9 mix). Two separate experiments with concentrations of 0, 1.95, 3.91, 7.81, 15.6, 31.3 nl/ml (experiment 1 and 0, 7.5, 10, 15, 20, 30, 40 nl/ml (experiment 2, both without metabilit activation) and 0, 3.91, 7.81, 15.6, 31.3, 62.5 nl/ml (experiment 1) or 0, 10, 15, 20, 30, 40, 60 nl/ml (experiment 2, both with metabolic activation) were performed.
All experiments were negative (with and without metabolic activation), the test material, orthochlorotoluene, did not induce significant increases in the mutant frequency at the TK locus in L5178Y mouse lymphoma cells. The test material was assayed up to 40 µl/ml without activation and 60 nl/ml with activation, and nondetectable to moderate toxicities were induced. Highly toxic treatments were not available for analysis because of a sharp toxicity curve. None of the assayed treatments induced a significant increase in the background. The test material is therefore considered inactive with and without metabolic activation in the mouse lymphoma forward mutation assay at concentrations that approached excessive toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.